C
AGN

Chescapmanager’s Allergan plc AGN Stock Holding History

Chescapmanager’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-100,000
Closed -$16.7M – 40
2019
Q2 		$16.7M Hold
100,000
– – 1.67% 18
2019
Q1 		$14.6M Buy
+100,000
New +$14.5M 1.74% 18
2018
Q1 		– Sell
-100,000
Closed -$16.4M – 49
2017
Q4 		$16.4M Hold
100,000
– – 2.67% 16
2017
Q3 		$20.5M Hold
100,000
– – 3.99% 5
2017
Q2 		$24.3M Buy
+100,000
New +$23.5M 4.1% 5

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Chescapmanager's AGN Position: Q2 2020 in Review

Chescapmanager sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 197,000 shares — an estimated $34.9M sold.

Chescapmanager first reported a position in AGN in Q4 2016 and held it in 14 quarters. The position peaked at $37.7M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Chescapmanager reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Chescapmanager sold 197,000 Allergan plc shares in Q2 2020, an estimated $34.9M.
  • Chescapmanager first reported a position in Allergan plc in Q4 2016 and held it in 14 quarters.
  • Chescapmanager's Allergan plc position peaked at $37.7M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Chescapmanager's 13F filing for Q2 2020, filed 14 Aug 2020.